Controlled Release Drug Delivery Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Date : November 2024

Controlled Release Drug Delivery Market Size Analysis and Top Companies

The global controlled release drug delivery market size is estimated at to hit around USD 149.65 billion by 2033 from USD 93.70 billion in 2024 with a CAGR of 9.26% from 2024 tpo 2033. The top companies operating in the controlled release drug delivery market are Merck and Co., Inc., Orbis Biosciences, Inc., Johnson and Johnson, Alkermes plc, Corium International, Inc., Coating Place, Inc., Pfizer, Inc., Depomed, Inc., Capsugel, Aradigm Corporation and Others.

Market Scope

Report Coverage Details
Market Size in 2024 USD 61.14 Billion
Market Size by 2034 USD 148.24 Billion
Growth Rate from 2023 to 2032 CAGR of 9.26%
Base Year 2023
Forecast Period 2024 to 2034
Segments Covered By Technology, By Release Mechanism and By Application
Regions Covered North America, Europe, Asia-Pacific, Latin America and Middle East & Africa

Controlled Release Drug Delivery Market Companies

Different businesses employ a wide variety of methods to ensure controlled discharge. Major pharmaceutical corporations also use controlled release techniques to broaden their customer base and deepen the penetration of their products. As a result, there is fierce competition between the market's numerous players and newcomers. 

Moreover, mergers and acquisitions by prominent players broaden their current product offerings. For instance, Capsugel announced the completion of the purchase of Xcelience and Powdersize in January 2016, which helped the business segment focus on the dosage form solutions of the company to extend its existing resources.

As numerous developers work to create medications that address particular patient needs, the market is tremendously fragmented. Major players are also working on cutting-edge controlled-release medication delivery systems. For instance, Capsugel announced the introduction of enTRinsic drug delivery technology in October 2015, which offers various compounds complete enteric protection and targeted delivery into the upper gastrointestinal tract. Leading companies in the global market for controlled-release medication delivery include:

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344